Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Vose

Showing results (61-70 of 140) with videos related to

Pageof 14
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1995
Costs of care and outcomes for high-dose therapy and autologous transplantation for lymphoid malignancies: results from the University of Nebraska 1987 through 1991C L Bennett, J L Armitage, G O Armitage, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 15, 2002
Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with recurrent indolent non-Hodgkin's lymphomaJ M Vose, P J Bierman, J C Lynch, et al.
Bone Marrow Transplantation|February 1, 1991
The use of recombinant human granulocyte-macrophage colony stimulating factor for the treatment of delayed engraftment following high dose therapy and autologous hematopoietic stem cell transplantation for lymphoid malignanciesJ M Vose, P J Bierman, A Kessinger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1996
Hodgkin's disease following solid organ transplantationP J Bierman, J M Vose, A N Langnas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1993
High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphomaJ M Vose, J R Anderson, A Kessinger, et al.
Bone Marrow Transplantation|June 1, 1996
Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor to enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignanciesJ M Vose, P J Bierman, E Ruby, et al.
Bone Marrow Transplantation|July 23, 1998
Epstein-Barr virus-associated lymphoproliferative disorder after autologous bone marrow transplantation: report of two casesR J Hauke, T C Greiner, B N Smir, et al.
Seminars in Hematology|April 1, 1994
Comparison of front-line chemotherapy for aggressive non-Hodgkin's lymphoma using the CAP-BOP regimens. The Nebraska Lymphoma Study GroupJ M Vose, J R Anderson, P J Bierman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993
Mesna compared with continuous bladder irrigation as uroprotection during high-dose chemotherapy and transplantation: a randomized trialJ M Vose, E C Reed, G C Pippert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1996
Single-photon emission computed tomography gallium imaging versus computed tomography: predictive value in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation for non-Hodgkin's lymphomaJ M Vose, P J Bierman, J R Anderson, et al.
Pageof 14

Showing results (61-70 of 140) with videos related to

Sort By:
Pageof 14
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1995
Costs of care and outcomes for high-dose therapy and autologous transplantation for lymphoid malignancies: results from the University of Nebraska 1987 through 1991C L Bennett, J L Armitage, G O Armitage, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 15, 2002
Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with recurrent indolent non-Hodgkin's lymphomaJ M Vose, P J Bierman, J C Lynch, et al.
Bone Marrow Transplantation|February 1, 1991
The use of recombinant human granulocyte-macrophage colony stimulating factor for the treatment of delayed engraftment following high dose therapy and autologous hematopoietic stem cell transplantation for lymphoid malignanciesJ M Vose, P J Bierman, A Kessinger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1996
Hodgkin's disease following solid organ transplantationP J Bierman, J M Vose, A N Langnas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1993
High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphomaJ M Vose, J R Anderson, A Kessinger, et al.
Bone Marrow Transplantation|June 1, 1996
Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor to enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignanciesJ M Vose, P J Bierman, E Ruby, et al.
Bone Marrow Transplantation|July 23, 1998
Epstein-Barr virus-associated lymphoproliferative disorder after autologous bone marrow transplantation: report of two casesR J Hauke, T C Greiner, B N Smir, et al.
Seminars in Hematology|April 1, 1994
Comparison of front-line chemotherapy for aggressive non-Hodgkin's lymphoma using the CAP-BOP regimens. The Nebraska Lymphoma Study GroupJ M Vose, J R Anderson, P J Bierman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993
Mesna compared with continuous bladder irrigation as uroprotection during high-dose chemotherapy and transplantation: a randomized trialJ M Vose, E C Reed, G C Pippert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1996
Single-photon emission computed tomography gallium imaging versus computed tomography: predictive value in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation for non-Hodgkin's lymphomaJ M Vose, P J Bierman, J R Anderson, et al.
Pageof 14